1-sulfanilyl-indole | 859965-28-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-sulfanilyl-indole
• 英文别名: 1-Sulfanilyl-indol；N-arenesulfonylindole antagonist, 10；4-indol-1-ylsulfonylaniline
• CAS: 859965-28-9
• 化学式: C₁₄H₁₂N₂O₂S
• 分子量: 272.327
• InChiKey: FLNRELDLHZADER-UHFFFAOYSA-N

物化性质

• 熔点：
  146-147 °C
• 沸点：
  515.2±52.0 °C(Predicted)
• 密度：
  1.35±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  73.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-甲基-3-(三氟甲基)-1H-吡唑-5-甲酰氯 、 1-sulfanilyl-indole 在 吡啶 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 N-(4-indol-1-ylsulfonylphenyl)-2-methyl-5-(trifluoromethyl)pyrazole-3-carboxamide
  参考文献：
  名称：

  Potent Non-Nucleoside Inhibitors of the Measles Virus RNA-Dependent RNA Polymerase Complex

  摘要：

  Measles virus (MV) is one of the most infectious pathogens known. In spite of the existence of a vaccine, approximately 350000 deaths/year result from MV or associated complications. Antimeasles compounds Could conceivably diminish these statistics and provide a therapy that complements vaccine treatment. We recently described a high-throughput screening hit compound 1 (16677) against MV-infected cells with the capacity to eliminate viral reproduction at 250 nM by inhibiting the action of the virus's RNA-dependent RNA polymerase complex (RdRp). The compound, 1-methyl-3-(trifluoroi-nethyl)-N-[4-sulfonylphenyl]-1H-pyrazole-5-carboxamide, 1 carries a critical CF3 moiety on the 1,2-pyrazole ring. Elaborating on the preliminary structure-activity (SAR) study, the present work presents the synthesis and SAR of a much broader range of low nanomolar nonpeptidic MV inhibitors and speculates on the role of the CF3 functionality.

  DOI：

  10.1021/jm701239a
• 作为产物：
  描述：

  对乙酰胺基苯磺酰氯 在 吡啶 、 sodium hydroxide 作用下， 生成 1-sulfanilyl-indole
  参考文献：
  名称：

  Rajagopalan, Proceedings - Indian Academy of Sciences, Section A, 1943, vol. 18, p. 100,101

  摘要：

  DOI：

文献信息

• [EN] AMINONAPTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES<br/>[FR] COMPOSÉ AMINO-NAPTHOQUINONE ET COMPOSITION PHARMACEUTIQUE BLOQUANT LE SYSTÈME UBIQUITINE-PROTÉASOME DANS DES MALADIES
  申请人：UNIV TAIPEI MEDICAL

  公开号：WO2017014788A1

  公开（公告）日：2017-01-26

  The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination- proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.

  这项发明涉及一种新的化合物，具有低细胞毒性，用于阻断疾病中的泛素化-蛋白酶体系统。因此，这些化合物可用于治疗包括但不限于癌症、神经退行性疾病、炎症性疾病、自身免疫性疾病和代谢性疾病在内的疾病。